Occurrence of advanced adenoma as a precancerous colorectal lesion is significantly higher in people with prediabetes and type 2 diabetes: a multicentre prospective study

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F19%3A00108626" target="_blank" >RIV/00216224:14110/19:00108626 - isvavai.cz</a>

Výsledek na webu

<a href="https://link.springer.com/article/10.1007/s00125-019-4946-6" target="_blank" >https://link.springer.com/article/10.1007/s00125-019-4946-6</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/s00125-019-4946-6" target="_blank" >10.1007/s00125-019-4946-6</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Occurrence of advanced adenoma as a precancerous colorectal lesion is significantly higher in people with prediabetes and type 2 diabetes: a multicentre prospective study

Popis výsledku v původním jazyce

The incidence and prevalence of both colorectal cancer (CRC) and metabolic syndrome (MS) is rising. The association of diabetes with an increased risk of gastrointestinal tumors is known. Less evidence is available of the relationship between MS and CRC precancerous lesions (adenomas, advanced adenomas). Screening is of crucial importance in early detection of curable stages of CRC. Aim was to study the occurrence of precancerous lesions/CRC in individuals at metabolic risk.

Název v anglickém jazyce

Occurrence of advanced adenoma as a precancerous colorectal lesion is significantly higher in people with prediabetes and type 2 diabetes: a multicentre prospective study

Popis výsledku anglicky

The incidence and prevalence of both colorectal cancer (CRC) and metabolic syndrome (MS) is rising. The association of diabetes with an increased risk of gastrointestinal tumors is known. Less evidence is available of the relationship between MS and CRC precancerous lesions (adenomas, advanced adenomas). Screening is of crucial importance in early detection of curable stages of CRC. Aim was to study the occurrence of precancerous lesions/CRC in individuals at metabolic risk.

Druh

O - Ostatní výsledky

CEP obor

—

OECD FORD obor

30202 - Endocrinology and metabolism (including diabetes, hormones)

Projekt

<a href="/cs/project/NV16-29614A" target="_blank" >NV16-29614A: Porovnání účinnosti kolonické kapslové endoskopie a optické kolonoskopie u osob s pozitivním imunochemickým testem na okultní krvácení do stolice</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2019

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů